End Stage Renal Disease on Dialysis Clinical Trial
— MHDOfficial title:
Application of Dyadic Psychological Intervention Strategy Based on Double ABC-X Model in Patients With Maintenance Hemodialysis
| NCT number | NCT06203730 |
| Other study ID # | LYZhang |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 1, 2024 |
| Est. completion date | July 1, 2024 |
This study aims explored the effectiveness of dual psychological intervention strategies in improving the quality of life of MHD patients based on the theoretical guidance of double ABC-X model. To provide a scientific and effective dual psychological intervention strategy for MHD patients and their caregivers, in order to improve the quality of life of MHD patients, and to provide a reference for nurses in clinical blood purification centers to implement psychological intervention.
| Status | Recruiting |
| Enrollment | 80 |
| Est. completion date | July 1, 2024 |
| Est. primary completion date | July 1, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - The inclusion criteria of MHD patients were: (1) meeting the diagnostic criteria of CKD; (2) Maintenance hemodialysis at the blood purification center of our hospital for more than 3 months; (3) over 18 years of age; (4) Volunteer to participate in this study. - MHD caregiver inclusion criteria: (1) over 18 years of age; (2) Responsible for the main care tasks of MHD patients; (3) Volunteer to participate in this study. Exclusion Criteria: - Exclusion criteria for MHD patients: (1) Patients with cognitive impairment or audio-visual impairment unable to communicate normally; (2) Patients diagnosed with mental illness or who are receiving medication or psychotherapy for depression. - MHD caregiver exclusion criteria: (1) Caregivers with cognitive impairment or audiovisual impairment unable to communicate normally; (2) Caregivers suffering from serious heart, brain, liver, kidney and other important organ diseases; (3) carers or paid carers. |
| Country | Name | City | State |
|---|---|---|---|
| China | Taizhou People's Hospital | Taizhou | Jiangsu |
| Lead Sponsor | Collaborator |
|---|---|
| Jiangsu Taizhou People's Hospital |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | quality of life of patients with MHD | The Kidney Disease Quality of Life 36-item Short Form (KDQOL-36™) was used to measure quality of life in patients with MHD | "Baseline" and "Immediately after the intervention" | |
| Primary | anxiety of patients with MHD | The hospital anxiety and depression scale (HADS) was used to measure anxiety in patients with MHD | "Baseline" and "Immediately after the intervention" | |
| Primary | depression of patients with MHD | The hospital anxiety and depression scale (HADS) was used to measure depression in patients with MHD | "Baseline" and "Immediately after the intervention" | |
| Secondary | anxiety of caregivers burden | The hospital anxiety and depression scale (HADS) was used to measure anxiety in caregivers | "Baseline" and "Immediately after the intervention" | |
| Secondary | depression of caregivers | The hospital anxiety and depression scale (HADS) was used to measure depression in caregivers | "Baseline" and "Immediately after the intervention" | |
| Secondary | caregivers'burden | The Zarit Caregiver Burden Interview (ZBI) was used to measure caregivers' burden | "Baseline" and "Immediately after the intervention" | |
| Secondary | Caregiving competence of caregivers | The Caregiving Competence Scale (CCS) was used to measure caregiving competence of caregivers | "Baseline" and "Immediately after the intervention" |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05978479 -
The Effect of Individualized Education Using the Teach-Back Method Treatment on Treatment Adherence and the Coping Skills
|
N/A | |
| Completed |
NCT06022835 -
Chlorhexidine Gluconate-gel Dressing for Exit Site Infection in Peritoneal Dialysis
|
N/A | |
| Completed |
NCT05540457 -
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
|
N/A | |
| Recruiting |
NCT04046042 -
Virtual Reality Intradialysis: Last vs. First Part of the Session
|
N/A | |
| Not yet recruiting |
NCT04527640 -
Effects of Synbiotics Supplementation on the Uremic Toxin Indoxyl Sulfate Level and Constipation in End-stage Renal Disease Patients Undergoing Hemodialysis
|
N/A | |
| Completed |
NCT05947708 -
The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300
|
N/A | |
| Recruiting |
NCT05735743 -
MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence
|
N/A | |
| Completed |
NCT04505462 -
Dietary Therapy in Dialysis Patients
|
N/A | |
| Active, not recruiting |
NCT04546958 -
Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia
|
N/A | |
| Recruiting |
NCT04286477 -
The Immune System in End Stage CKD Patients - Comparison Among Different Modalities of RRT
|
||
| Completed |
NCT04487301 -
A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease
|
||
| Recruiting |
NCT05677555 -
Colchicine and Inflammation in Hemodialysis Patients
|
Phase 2 | |
| Completed |
NCT04789876 -
Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia
|
N/A | |
| Completed |
NCT04125537 -
Pathways Project: Kidney Supportive Care
|
||
| Suspended |
NCT05915286 -
Diuretic Use in Hemodialysis Patients With Residual Renal Function
|
Phase 4 | |
| Completed |
NCT04912050 -
EXtension of Tablo TrEatmeNt Duration Registry
|
||
| Recruiting |
NCT04360694 -
RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE)
|
N/A | |
| Recruiting |
NCT04501159 -
pH, Hypoxia and Haemodialysis
|
||
| Recruiting |
NCT05032651 -
Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
|
N/A | |
| Completed |
NCT04806126 -
Evaluation of a Virtual Home Dialysis Mentoring Program (Home)
|